Rybelsus is the first and only FDA-approved oral GLP-1 receptor agonist for treating type 2 diabetes.Todos os Direitos Reservados
Rybelsus is the first and only FDA-approved oral GLP-1 receptor agonist for treating type 2 diabetes.
1 part